ABVC BIOPHARMA, INC. (ABVC) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$1.89M2011: -$1.89M2012: -$1.14M2013: -$177.3K2016: -$11.00M2017: -$4.14M2018: -$2.78M2019: -$3.46M2020: -$8.51M2021: -$11.71M2022: -$15.11M2023: -$6.77M2024: -$4.71M2025: -$7.15M-$7.15M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$7.15M-52.0%
2024-$4.71M+30.5%
2023-$6.77M+55.2%
2022-$15.11M-29.1%
2021-$11.71M-37.6%
2020-$8.51M-145.9%
2019-$3.46M-24.2%
2018-$2.78M+32.7%
2017-$4.14M+62.4%
2016-$11.00M
2013-$177.3K+84.5%
2012-$1.14M+39.5%
2011-$1.89M+0.1%
2010-$1.89M